Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Spero Therapeutics, Inc. | spro-ex322_6.htm |
| EX-32.1 - EX-32.1 - Spero Therapeutics, Inc. | spro-ex321_11.htm |
| EX-31.2 - EX-31.2 - Spero Therapeutics, Inc. | spro-ex312_13.htm |
| EX-31.1 - EX-31.1 - Spero Therapeutics, Inc. | spro-ex311_14.htm |
| EX-23.1 - EX-23.1 - Spero Therapeutics, Inc. | spro-ex231_10.htm |
| EX-10.13 - EX-10.13 - Spero Therapeutics, Inc. | spro-ex1013_338.htm |
| EX-10.12 - EX-10.12 - Spero Therapeutics, Inc. | spro-ex1012_337.htm |
| EX-10.6 - EX-10.6 - Spero Therapeutics, Inc. | spro-ex106_372.htm |
| EX-4.3 - EX-4.3 - Spero Therapeutics, Inc. | spro-ex43_371.htm |
| 10-K - 10-K - Spero Therapeutics, Inc. | spro-10k_20191231.htm |
Exhibit 21.1
SUBSIDIARIES OF SPERO THERAPEUTICS, INC.
|
|
|
|
|
Subsidiary |
|
Jurisdiction |
|
New Pharma License Holdings |
|
Malta |
|
Spero Cantab, Inc. |
|
Delaware |
|
Spero Cantab UK Limited |
|
England and Wales |
|
Spero Europe, Ltd. |
|
England and Wales |
|
Spero Legacy STI, Inc. |
|
Delaware |
|
Spero Potentiator, Inc. |
|
Delaware |
|
Spero Potentiator PTY LTD |
|
Australia |
|
Spero Securities Corporation |
|
Massachusetts |